GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Total Stockholders Equity

Benevolent AI (Benevolent AI) Total Stockholders Equity : $119.33 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Total Stockholders Equity?

Benevolent AI's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $119.33 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Benevolent AI's Book Value per Share for the quarter that ended in Dec. 2023 was $0.96. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Benevolent AI's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.05.

Benevolent AI Total Stockholders Equity Historical Data

The historical data trend for Benevolent AI's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Total Stockholders Equity Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 164.51 164.82 81.05 187.58 119.33

Benevolent AI Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 81.05 204.90 187.58 155.93 119.33

Benevolent AI  (GREY:BAIVF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Benevolent AI's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(119.33-0)/124.44
=0.96

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Benevolent AI's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.171 + 4.839) / 119.33
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benevolent AI Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (Benevolent AI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
BAI:Netherlands 2XA:Germany
Address
4-8 Maple Street, London, GBR, W1T 5HD
Website
https://www.benevolent.com
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.